QHSLab Q3 revenue up 62% to $544K, net income $49.8K, gross margin 67.1%

QHSLab, Inc.

2024-Q3 EPS reported $0.00 revenue$1,505,945

Revenue $544,285 (+62% YoY); gross margin 67.1% (up from 56.3%). Net income $49,765 vs ($82,000) loss in Q3 2023.
ISP (digital health) segment revenue up 126% in Q3 to ~$162K; YTD growth 143% to ~$450K.
Allergy kit sales +48% YoY to ~$220K. Surpassed 100,000 completed digital assessments.
Debt reduction of >$100K from operating cash flow; R&D investment up to $187K YTD.
Secured ~$300K grant for allergic rhinitis digital health research.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.